Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Sponsor: HIV Prevention Trials Network
Summary
To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Official title: A Multisite, Open-label, Randomized Crossover Study Comparing Adherence to a Single Daily Dual Prevention Pill (DPP) Versus FTC/TDF and Combined Oral Contraception Separate Pill Dosing (2PR), Given for Pre-exposure Prophylaxis and Pregnancy Prevention in Women
Key Details
Gender
FEMALE
Age Range
16 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-05-15
Completion Date
2028-05-15
Last Updated
2026-02-19
Healthy Volunteers
Yes
Conditions
Interventions
DPP
Daily, single, co-formulated, FTC/TDF + combined ethinyl estradiol/levonorgestrel oral contraceptive pill
2PR
Daily, two-pill regimen of oral FTC/TDF and ethinyl estradiol/levonorgestrel oral contraceptive pill
Free Choice
Choice of either DPP or 2PR
Locations (3)
Eswatini Prevention Center CRS
Mbabane, Eswatini
MU-JHU Research Collaboration (MUJHU CARE LTD) CRS
Kampala, Uganda
Spilhaus CRS
Harare, Zimbabwe